col blocks we are bridge builder col blocks
COVID Antworten in den wissenschaftlichen Zeitschriften der Welt


44 Ergebisse       Seite 1

 [1] 
Elsevier: Computational Biology and Chemistry
  Original Artikel Datum Titel Autoren   Alle Autoren
1 [GO] 2023―Sep―21 A Bioinformatic Analysis: Previous allergen exposure may support anti- SARS-CoV-2 immune response Işil Kutluturk Karagoz, Mucahit Kaya, René Rückert, Nazli Bozman, Vildan Kaya, Halim Bayram, Mustafa Yildirim
2 [GO] 2023―Sep―20 Computational analysis of substrate recognition of Sars-Cov-2 Mpro main protease Hilal Sena Tasci, Ebru Akkus, Muslum Yildiz, Abdulkadir Kocak
3 [GO] 2023―Sep―09 COMPUTATIONAL ANALYSIS OF THE INTERACTIONS BETWEEN EBSELEN AND DERIVATIVES WITH THE ACTIVE SITE OF THE MAIN PROTEASE FROM SARS-COV-2 Guilherme Schmitt Rieder, Pablo Andrei Nogara, Folorunsho Bright Omage, Tâmie Duarte, Cristiane Lenz Dalla Corte, João Batista Teixeira da Rocha
4 [GO] 2023―Aug―16 A Deep-SIQRV Epidemic Model for COVID-19 to Access the Impact of Prevention and Control Measures Aakansha Gupta, Rahul Katarya
5 [GO] 2023―Jul―19 ReGen-DTI: A novel generative drug target interaction model for predicting potential drug candidates against SARS-COV2 Kaushik Bhargav Sivangi, Santhosh Amilpur, Chandra Mohan Dasari
6 [GO] 2023―Jul―07 Role of Molecular Mimicry in the SARS-CoV-2-Human Interactome for Pathogenesis of Cardiovascular Disease: An Update to ImitateDB Sonali Tayal, Sonika Bhatnagar
7 [GO] 2023―Jul―06 Terpenoid phytocompounds from mangrove plant Xylocarpus moluccensis as possible inhibitors against SARS-CoV-2: In silico strategy Kiran Bharat Lokhande, Arti Kale, Bhagyashree Shahakar, Ashish Shrivastava, Neelu Nawani, K. Venkateswara Swamy, et al. (+2)
8 [GO] 2023―Mai―24 Inflammation Inhibitory Activity of Green Tea, Soybean, and Guava Extracts During Sars-Cov-2 Infection Through TNF Protein in Cytokine Storm Didik Priyandoko, Wahyu Widowati, Hanna Sari Widya Kusuma, Ervi Afifah, Cahyaning Rizki Wijayanti, Rizal Rizal, et al. (+4)
9 [GO] 2023―Jan―05 QM/MM study of N501 involved intermolecular interaction between SARS-CoV-2 receptor binding domain and antibody of human origin Yuemin Liu, Hana F. Sulaiman, Bruce R. Johnson, Rulong Ma, Yunxiang Gao, Harshica Fernando, et al. (+5)
10 [GO] 2023―Jan―03 Extraction of Knowledge Graph of Covid-19 Through Mining of Unstructured Biomedical Corpora Sudhakaran Gajendran, D Manjula, Vijayan Sugumaran, R Hema
11 [GO] 2022―Sep―07 Dual Computational and Biological Assessment of Some Promising Nucleoside Analogs against the COVID-19-Omicron Variant Mohnad Abdalla, Amgad M. Rabie
12 [GO] 2022―Aug―18 Exploiting reverse vaccinology approach for the design of a multiepitope subunit vaccine against the major SARS-CoV-2 variants Daniel Melo de Oliveira Campos, Maria Karolaynne da Silva, Emmanuel Duarte Barbosa, Chiuan Yee Leow, Umberto Laino Fulco, Jonas Ivan Nobre Oliveira
13 [GO] 2022―Jun―28 A computational essential dynamics approach to investigate structural influences of ligand binding on Papain like protease from SARS-CoV-2 Ekampreet Singh, Rajat Kumar Jha, Rameez Jabeer Khan, Ankit Kumar, Monika Jain, Jayaraman Muthukumaran, Amit Kumar Singh
14 [GO] 2022―Mai―14 Interaction of the New Inhibitor Paxlovid (PF-07321332) and Ivermectin With the Monomer of the Main Protease SARS-CoV-2: A Volumetric Study Based on Molecular Dynamics, Elastic Networks, Classical Thermodynamics and SPT Ysaias José Alvarado, Yosmari Olivarez, Carla Lossada, Joan Vera-Villalobos, José Luis Paz, Eddy Vera, et al. (+6)
15 [GO] 2022―Mai―11 A multilevel approach for screening natural compounds as an antiviral agent for COVID-19 Mahdi Vasighi, Julia Romanova, Miroslava Nedyalkova
16 [GO] 2022―Apr―30 A new approach for determining SARS-CoV-2 epitopes using machine learning-based in silico methods Pınar Cihan, Zeynep Banu Ozger
17 [GO] 2022―Apr―29 Computational study and design of effective siRNAs to silence structural proteins associated genes of Indian SARS-CoV-2 strains Premnath Madanagopal, Harshini Muthukumar, Kothai Thiruvengadam
18 [GO] 2022―Apr―09 A Composite Ranking of Risk Factors for COVID-19 Time-To-Event Data from a Turkish Cohort Ayse Ulgen, Sirin Cetin, Meryem Cetin, Hakan Sivgin, Wentian Li
19 [GO] 2022―Apr―06 Mathematical modeling and analysis of the SARS-Cov-2 disease with reinfection Asghar Atifa, Muhammad Altaf Khan, Kulpash Iskakova, Fuad S. Al-Duais, Irshad Ahmad
20 [GO] 2022―Mrz―28 SARS-CoV-2 3CLpro whole human proteome cleavage prediction and enrichment/depletion analysis Lucas Prescott
21 [GO] 2022―Mrz―23 Glycosylation is key for enhancing drug recognition into spike glycoprotein of SARS-CoV-2 Georcki Ropón-Palacios, Jhon Pérez-Silva, Ricardo Rojas-Humpire, Gustavo E. Olivos-Ramírez, Manuel Chenet-Zuta, Victor Cornejo-Villanueva, et al. (+5)
22 [GO] 2022―Feb―26 Design and various in silico studies of the novel curcumin derivatives as potential candidates against COVID-19 -associated main enzymes Hakan Alici, Hakan Tahtaci, Kadir Demir
23 [GO] 2022―Feb―26 Machine learning prediction of 3CLpro SARS-CoV-2 docking scores Lukas Bucinsky, Dušan Bortňák, Marián Gall, Ján Matúška, Viktor Milata, Michal Pitoňák, et al. (+3)
24 [GO] 2022―Feb―19 A Global Report on the Dynamics of COVID-19 with Quarantine and Hospitalization: A Fractional Order Model with Non-Local Kernel Zubair Ahmad, Sherif A. El-Kafrawy, Thamir A. Alandijany, Francesco Giannino, Ahmed A. Mirza, Mai M. El-Daly, et al. (+4)
25 [GO] 2021―Dez―01 Molecular dynamic simulation analysis of SARS-CoV-2 spike mutations and evaluation of ACE2 from pets and wild animals for infection risk Ping Chen, Jingfang Wang, Xintian Xu, Yuping Li, Yan Zhu, Xuan Li, et al. (+2)
26 [GO] 2021―Nov―20 SARS-CoV-2: Can sunlight exposure reduce the risk of developing severe consequences of COVID-19? Jibran Sualeh Muhammad, Ruqaiyyah Siddiqui, Naveed Ahmed Khan
27 [GO] 2021―Nov―02 Comprehensive analyses of bioinformatics applications in the fight against COVID-19 pandemic Lifei Ma, Huiyang Li, Jinping Lan, Xiuqing Hao, Huiying Liu, Xiaoman Wang, Yong Huang
28 [GO] 2021―Okt―26 Polymorphic landscape of SARS-CoV-2 genomes isolated from Indian population in 2020 demonstrates rapid evolution in ORF3a, ORF8, nucleocapsid phosphoprotein and spike glycoprotein Archana Pal, Shefali Dobhal, Kishore Kumar Dey, Anish Kumar Sharma, Vivek Savani, Vishal Singh Negi
29 [GO] 2021―Sep―02 Potential Achilles heels of SARS-CoV-2 are best displayed by the base order-dependent component of RNA folding energy Chiyu Zhang, Donald R. Forsdyke
30 [GO] 2021―Jul―30 Modelling the spread of covid-19 in the capital of Brazil using numerical solution and cellular automata André Luís Brasil Cavalcante, Lucas Parreira de Faria Borges, Moisés Antônio da Costa Lemos, Márcio Muniz de Farias, Hervaldo Sampaio Carvalho
31 [GO] 2021―Jul―05 Efficient Machine Learning Model for Predicting Drug-Target Interactions with Case Study for Covid-19 Heba El-Behery, Abdel-Fattah Attia, Nawal El-Feshawy, Hanaa Torkey
32 [GO] 2021―Jun―19 A computational analysis of molecular evolution for virulence genes of zoonotic novel coronavirus (COVID-19) Priya Kumari, Raju Poddar
33 [GO] 2021―Jun―18 Molecular insight into the genomic variation of SARS-CoV-2 strains from current outbreak Avizit Das, Sarah Khurshid, Aleya Ferdausi, Eshita Sadhak Nipu, Amit Das, Fee Faysal Ahmed
34 [GO] 2021―Mai―06 Designing Potential siRNA Molecule for the Nucleocapsid(N) Gene Silencing of Different SARS-CoV-2 Strains of Bangladesh: Computational Approach Syed Shahariar Bappy, Abu Zaffar Shibly, Sorna Sultana, A.K.M. Mohiuddin, Yearul Kabir
35 [GO] 2021―Mrz―29 Exploring the effectiveness of the TSR-based protein 3-D structural comparison method for protein clustering, and structural motif identification and discovery of protein kinases, hydrolase, and SARS-CoV-2’s protein via the application of amino acid grouping Titli Sarkar, Vijay V. Raghavan, Feng Chen, Andrew Riley, Sophia Zhou, Wu Xu
36 [GO] 2021―Feb―21 Docking-based virtual screening studies aiming at the covalent inhibition of SARS-CoV-2 MPro by targeting the cysteine 145 Laurent Soulère, Thibaut Barbier, Yves Queneau
37 [GO] 2020―Nov―05 Genetic analysis of SARS-CoV-2 isolates collected from Bangladesh: Insights into the origin, mutational spectrum and possible pathomechanism Md. Sorwer Alam Parvez, Mohammad Mahfujur Rahman, Md. Niaz Morshed, Dolilur Rahman, Saeed Anwar, Mohammad Jakir Hosen
38 [GO] 2020―Okt―23 Interaction of small molecules with the SARS-CoV-2 main protease in silico and in vitro validation of potential lead compounds using an enzyme-linked immunosorbent assay Eleni Pitsillou, Julia Liang, Chris Karagiannis, Katherine Ververis, Kevion K. Darmawan, Ken Ng, et al. (+2)
39 [GO] 2020―Sep―13 Identification of novel human USP2 inhibitor and its putative role in treatment of COVID-19 by inhibiting SARS-CoV-2 papain-like (PLpro) protease Muhammad Usman Mirza, Sarfraz Ahmad, Iskandar Abdullah, Matheus Froeyen
40 [GO] 2020―Sep―06 Site mapping and small molecule blind docking reveal a possible target site on the SARS-CoV-2 main protease dimer interface Julia Liang, Chris Karagiannis, Eleni Pitsillou, Kevion K. Darmawan, Ken Ng, Andrew Hung, Tom C. Karagiannis
41 [GO] 2020―Aug―01 An in-silico approach to study the possible interactions of miRNA between human and SARS-CoV2 Abhijit Sarma, Homen Phukan, Neha Halder, Madathiparambil Gopalakrishnan Madanan
42 [GO] 2020―Jul―31 Repurposing approved Drugs as potential Inhibitors of 3CL-protease of SARS-CoV-2: Virtual screening and Structure Based Drug Design Franz-Josef Meyer-Almes
43 [GO] 2020―Jun―25 Virtual screening of approved drugs as potential SARS-CoV-2 main protease inhibitors Alicia Jiménez-Alberto, Rosa María Ribas-Aparicio, Gerardo Aparicio-Ozores, Juan A. Castelán-Vega
44 [GO] 2020―Mai―28 Interaction of the prototypical α-ketoamide inhibitor with the SARS-CoV-2 main protease active site in silico: Molecular dynamic simulations highlight the stability of the ligand-protein complex Julia Liang, Eleni Pitsillou, Chris Karagiannis, Kevion K Darmawan, Ken Ng, Andrew Hung, Tom C. Karagiannis
 [1] 

44 Ergebisse       Seite 1



[de][en]

Letzte Änderung 2023―Okt―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.004 sec